Harness IP’s team of attorneys has a singular focus: intellectual property. We are frequently interviewed by media sources about topics and developments in IP law, and regularly share practical insights for managing IP risks in a variety of publications. Our patent and trademark attorneys also present at events or via webinars on the latest updates in IP Law.

Articles, News
May 25, 2023
“From FTC to SCOTUS, Amgen’s Woes are Potential ‘Game Changers’ for the Industry” PharmaVoice


Awards, News, Press Releases
May 22, 2023
Harness IP Earns Mansfield Rule Certification for Midsize Firms


Events, News, Press Releases
May 16, 2023
Joseph E. Walsh appointed by the United States District Court


Articles, Events, News
May 14, 2023
U.S. & Unitary Patent: “Low Barrier to Pan-Europe Rights” – Harness Special Counsel John White Interviewed by Kluwer Patent Blog

News, Press Releases
May 12, 2023
Harness IP Attorney Michael Doerr Helps School Robotics Team Secure Patent for Scooter Safety Technology


News, Press Releases
April 27, 2023
Harness IP Attorney Joel Samuels Tapped for St. Louis County Industrial Development Authority Board


News, Press Releases
April 6, 2023
Harness IP Attorney Glenn Forbis Represents Maravilla in Major Eye, Brain Health IP Acquisition


Articles, News, Press Releases
March 31, 2023
“US Supreme Court Weighs Biologics Patents in Amgen vs. Sanofi Case,” PharmTech and BioPharm International

Articles
March 29, 2023
Au contraire, mon frere! It’s our Gruyere – Cheese trademark case offers lessons for attorneys

Articles, News, Press Releases
March 29, 2023
“Lawmakers Press FDA on Clinical Trial Holds,” Politico

Articles, News, Press Releases
March 28, 2023
“SCOTUS to Decide ‘Fundamental Change’ in Biologics Patents with Fate of Amgen v. Sanofi,” PharmaVoice


News, Press Releases
March 14, 2023